XLON
VRS
Market cap806kUSD
Nov 28, Last price
0.01GBP
Name
Versarien PLC
Chart & Performance
P/E
—
P/S
0.25
EPS
—
Div Yield, %
—
Shrs. gr., 5y
51.97%
Rev. gr., 5y
-21.79%
Revenues
2m
-55.51%
Net income
-4m
L-69.53%
CFO
-2m
L-37.40%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Versarien plc, a UK-based engineering materials firm established in 2010 and headquartered in Cheltenham, delivers specialized engineering solutions to a wide array of industries across the United Kingdom, Europe, North America, and other international territories. The company's operations are segmented into two key divisions: Graphene and Plastic Products, and Hard Wear and Metallic Products. The Graphene and Plastic Products division pioneers advanced graphene materials, featuring Nanene, a few-layer graphene; Polygrene, a graphene-enhanced polymer; and Hexotene, a few-layer hexagonal boron nitride nano-platelet powder. It also develops graphene-based nanomaterials for energy storage applications and offers a comprehensive range of electrically conductive Graphinks designed for various printing processes, substrates, and uses. Additionally, this segment manufactures graphene-enhanced plastic items such as mobile accessories, injection molded components, toolboxes, transit trays, PU foam tanks, and vacuum-formed products. The Hard Wear and Metallic Products division specializes in sintered tungsten carbide products. These include custom inserts and blanks, cutting tools, wear-resistant parts, nozzles and valve inserts for flow regulation, and durable tungsten carbide components for defense and aerospace applications in demanding environments. This division further produces micro-porous metals for thermal management solutions and supplies extruded aluminum products, including industrial components and heat sinks. Beyond these core offerings, Versarien also manufactures and distributes anti-bacterial and antiviral masks, hospital bed panels, and protective visors.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||